In agreement with findings in GBM, by performing an immunohistochemical analysis in a cohort of 200 human TNBC samples, we found that the tumor cell expression of PDGFRβ marks a restricted subgroup of tumors (5.5% of total cases) with invasive and mesenchymal/stem-like phenotype [59]. Here, PDGFRB is linked to neoplasm.